BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27268144)

  • 21. Surface plasmon resonance analysis of seven-transmembrane receptors.
    Aristotelous T; Hopkins AL; Navratilova I
    Methods Enzymol; 2015; 556():499-525. PubMed ID: 25857797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of ligands for G protein-coupled receptor stability.
    Zhang X; Stevens RC; Xu F
    Trends Biochem Sci; 2015 Feb; 40(2):79-87. PubMed ID: 25601764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands.
    Freudenberg JM; Dunham I; Sanseau P; Rajpal DK
    BMC Bioinformatics; 2018 Oct; 19(1):345. PubMed ID: 30285606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budded baculoviruses as a receptor display system to quantify ligand binding with TIRF microscopy.
    Laasfeld T; Ehrminger R; Tahk MJ; Veiksina S; Kõlvart KR; Min M; Kopanchuk S; Rinken A
    Nanoscale; 2021 Feb; 13(4):2436-2447. PubMed ID: 33464268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Binding Kinetics in GPCR Drug Discovery.
    Swinney DC; Haubrich BA; Van Liefde I; Vauquelin G
    Curr Top Med Chem; 2015; 15(24):2504-22. PubMed ID: 26126905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence based HTS-compatible ligand binding assays for dopamine D
    Tahk MJ; Laasfeld T; Meriste E; Brea J; Loza MI; Majellaro M; Contino M; Sotelo E; Rinken A
    Front Mol Biosci; 2023; 10():1119157. PubMed ID: 37006609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Residence Time of GPCR Ligands with Machine Learning.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2022; 2390():191-205. PubMed ID: 34731470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guiding lead optimization with GPCR structure modeling and molecular dynamics.
    Heifetz A; James T; Morao I; Bodkin MJ; Biggin PC
    Curr Opin Pharmacol; 2016 Oct; 30():14-21. PubMed ID: 27419904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
    Patching SG
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
    Vedel L; Bräuner-Osborne H; Mathiesen JM
    J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budded baculovirus particles as a source of membrane proteins for radioligand binding assay: The case of dopamine D
    Allikalt A; Rinken A
    J Pharmacol Toxicol Methods; 2017 Jul; 86():81-86. PubMed ID: 28412328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.